Clinical trial
Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who…
NCT00054626 · Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy, Other · Unknown status
Key facts
| NCT number | NCT00054626 |
|---|---|
| Title | Cisplatin and Gemcitabine Compared With Observation in Treating Patients Who Have Undergone Surgery for Bladder Cancer |
| Official title | Phase III Study Of Adjuvant Cisplatin-Gemcitabine Vs. Observation After Radical Cystectomy In High-Risk Bladder Cancer |
| Lead sponsor | Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bladder Cancer |
| Intervention type | Drug, Procedure |
| Interventions | cisplatin, gemcitabine hydrochloride, adjuvant therapy |
| Enrollment | 700 |
| Start date | Sep 1, 2001 |
| Primary completion | Jun 1, 2008 |
| First posted | Feb 6, 2003 |
| Last update posted | Dec 18, 2013 |
| Countries | Italy |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: